Life Sciences Blog

Focused on the Business of Healthcare and Healthcare Innovation

Lifecycle Management (Chapter 7) Historically, drugs are approved for an initial indication; then the lifecycle management team pursued additional indications.  Rarely were indications revoked by regulators, so the potential market usually increased indication by indication.  Within each indication, companies competed for market share. Personalized Medicine Implications As our understanding of genomics increases, it is likely …

Read more »

Summary and Recommendations (Chapter Eight) Personalized medicine has arrived, and its impact has only begun to be felt across the healthcare ecosystem.  In this article, we have illustrated how personalized medicine is likely to change the pharmaceutical industry, historically one of the riskiest yet most profitable parts of the healthcare ecosystem. When one contemplates the …

Read more »